“How can biopharma improve?” This question is the guiding ethos of the Better Biopharma podcast. Through conversations with experts across the biopharma landscape, host Tyler Menichiello explores the work being done to make better medicines and optimize manufacturing. Each episode is a dive into the guest's methods, their curiosity, and their determination. By shining a light on the visionaries pushing the industry forward, Better Biopharma aims to inform and inspire their peers to continue ...
…
continue reading
Biopharma Podcasts
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The B ...
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Each episode explores the challenges and considerations involved with bringing biopharmaceuticals to the market.
…
continue reading
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Eva ...
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
…
continue reading
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a vid ...
…
continue reading
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email [email protected] or call our listener voicemail line at 206-984-3214.
…
continue reading
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
…
continue reading
Your trusted partner in pharmaceutical manufacturing. We specialize in high-quality, innovative pharmaceutical products, ensuring healthcare solutions that meet global standards.
…
continue reading
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stak ...
…
continue reading
Tune in to industry innovators sharing real experiences – turning digital potential into a competitive advantage and improving patient outcomes. Previously known as Driving Digital in Biopharma.
…
continue reading
Running studies is hard. Finding clear answers wastes time. This podcast shares what works, straight from COG sessions recorded across the series and curated for people delivering trials. You get focused lessons on study design and feasibility, start-up speed, country and site activation, recruitment and retention, site partnerships, data quality, and inspection readiness. Built for Heads and Directors of Clinical Operations, study and programme leads, CPMs and CTMs in small to mid biopharma ...
…
continue reading
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
…
continue reading
Join Nancy Donohoo's bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy's guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
…
continue reading
BioPharma Unscripted! connects leaders across biotech, pharma and healthcare to share insights that bridge US and European markets. Hosted by Marcus Metcalfe, this podcast brings together emerging biotech leaders, market access specialists and industry innovators to explore the challenges and opportunities in bringing life-changing treatments to patients. Each episode features thought-provoking conversations with industry experts who share their journeys, strategies and practical advice on n ...
…
continue reading
Lean by Design explores how organizations can fix what’s predictably broken in their operations — starting with the systems, decisions, and behaviors that shape how work gets done. Hosts Oscar Gonzalez and Lawrence Wong speak with leaders from biopharma and beyond, drawing lessons from industries that share the same pursuit of clarity, efficiency, and sustainable execution. Each episode breaks down real challenges into practical insights that help teams align better, think smarter, and move ...
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
1
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Julio G. Martinez-Clark
0
113
Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia. What You’ll Learn: Speed Secrets: How t ...
…
continue reading
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, ...
…
continue reading
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
…
continue reading
1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation
David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist
3218
The Go-to Podcast for Biotech Scientists Who Want to Master Biopharma CMC Development and Biomanufacturing. **TOP 10 LIFE SCIENCES PODCAST** Are you ready to simplify bioprocess development and scale with confidence to reduce time to market? Are you feeling overwhelmed by the complexity and guesswork of biologics development and biomanufacturing? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercializ ...
…
continue reading
Kurt Wehrle is a Chicago-based enterprising worldwide business pioneer with 20+ long periods of assorted and progressive P&L management in top-notch Biopharma, Medical Device, and Diagnostic organizations. Kurt Wehrle has a demonstrated history of creating multi-layered worldwide systems, building frameworks, changing business, extending topographies, and creating on the web capacities to essentially expand income and EBITDA.
…
continue reading
In conversation with leaders and experts, McKinsey's At the Edge podcast demystifies cutting-edge technologies and shares strategies on how companies can capture big opportunities.
…
continue reading
ThinkrTalk is the only podcast spotlighting the bold ideas and breakthroughs happening at the intersection of biopharma, healthcare technology and investment. We’ll bring you smart conversations with the TRAILBLAZERS transforming patient care—from inside pharma, scaling health techs, or leading the charge in funding the next big innovation. Expect real-world advice, fresh perspectives, and stories that fuel action. Whether you’re an industry veteran or just breaking into the space, ThinkrTa ...
…
continue reading
Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
The Life Sciences D’n’A podcast is hosted by AI and data analytics experts and pharma industry veterans Nagaraja Srivatsan and Amar Drawid. They explore the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
…
continue reading
Welcome to Risk Revolution! The goal of this series is to advance the maturity of risk management practices within the industry, by covering topics that challenge quality professionals to seek opportunities to improve and advance the ways in which they perceive and manage risk. The hosts for this series are Nuala Calnan, Valerie Mulholland, and Lori Richter.
…
continue reading
Your Brain On... is a podcast by Learning and Development professionals for Learning and Development professionals. Every day, Salience Learning combines the science of learning with expertise in the business of science to help solve the biopharma industry's most complex business challenges. Listen as hosts Karen Foster and Krista Gerhard discuss the latest in cognitive science and learning strategies as they relate to the ever-evolving healthcare industry. In other words: Your Brain On... g ...
…
continue reading
One-on-one with medical innovators Breakthrough medicines, billion-dollar deals, spectacular clinical successes and crushing failures all play a part in biopharma’s dynamic story. Developers make scientific advancements with the potential to change everything, only to face regulatory conundrums and ever-fluctuating markets. BioWorld tracks key events in the fast-moving sector every business day. Now, the BioWorld Insider podcast lets you hear directly from the movers and shakers whose collec ...
…
continue reading
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
…
continue reading
LARVOL & Friends is a must-listen for anyone interested in hearing about insights and exclusive takes from industry experts and business leaders about the evolution, intersection and future of biopharma, technology, business, and competitive intelligence! Since 2004, LARVOL has been accelerating decision-making by providing real-time, customized intelligence and software solutions with data-driven analytics to the most prominent pharmaceutical, biotech, and healthcare companies in the world. ...
…
continue reading
A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.
…
continue reading
Presented by Kymanox, Life Science Solutions is dedicated to accelerating understanding and advancing expertise in the life sciences industry. Focused on bringing industry insights to light, our podcast offers a platform where regulatory, scientific, and engineering experts share practical knowledge on overcoming the challenges of product development and commercialization. Episodes equip listeners with the latest on regulatory updates, market trends, cutting-edge technology, and more. Join u ...
…
continue reading
The Flagship Podcast brings you inside stories from the Canadian technology ecosystem. You'll hear from founders, investors, builders and learn about their triumphs, hardships and hard earned lessons. You'll learn about strategies and tactics and about the human side and what it takes to build a thriving technology company which will hopefully help you on your journey.
…
continue reading
HedgeD, with a capital "D" for emphasis, brings listeners topical content from both sides of the ledger – the long side and the short side. In each episode, co-hosts Mark Yusko, Cory Lester and Andrew Schmeelk take a deep dive into an investment theme or concept, typically with the help of an expert guest from Morgan Creek's expansive global network.
…
continue reading
Watch the #1 Biotech Podcast in Europe to grow. Hosted by Philip Hemme. 25k monthly views. Free. Guests include Antoine Papiernik @Sofinnova, Werner Lanthaler @Evotec, Ingmar Hoerr @CureVac, Bernat Olle @Vedanta, Johannes Fruehauf @BioLabs, Rodger Novak @CRISPR Tx, Agnete Fredriksen @Nykode, Mike Ward, Thomas Clozel @Owkin, Marc de Garidel @Abivax, Sander van Deventer @VectorY & Forbion, Jens Nielsen @BII, Edwin Moses, Bahija Jallal @Immunocore, and more. Your host Philip animates the conver ...
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
A myriad of AI, science, and technology experts explore the real challenges and enormous opportunities facing entrepreneurs who are building the future of health. Raising Health, a podcast by a16z Bio + Health, dives deep into the heart of biotechnology and healthcare innovation. Join veteran company builders, operators, and investors Vineeta Agarwala, Julie Yoo, and Jorge Conde, along with distinguished guests like Mark Cuban, Greg Verdine, Fei-Fei Li, and Suchi Saria, as they explore the i ...
…
continue reading
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, ...
…
continue reading
1
Rare Insights: Uncovering The Future Of Rare Disease Treatments
Know Rare (Taren Grom, Liz Kay, Kaitlyn Taylor, Nina Wachsman, and DNA Today’s Kira Dineen)
05
On “Rare Insights” we bridge the gap between those living with rare diseases and the biopharmaceutical industry. Know Rare amplifies the voices of individuals with rare conditions, providing invaluable perspectives to accelerate therapeutic solutions. Join us as we dive deep into the complexities of rare diseases, exploring real-world insights from passionate industry leaders. Together, we navigate the unknowns and unlock the potential for groundbreaking treatments. Because in this journey, ...
…
continue reading
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantical ...
…
continue reading
Tune into our new Pharmaceuticals and Life Sciences podcast to hear the latest insights from Baringa's experts.
…
continue reading
Curious about what biomedical science PhDs do for their career? In the "Beyond the Lab" podcast series, the Vanderbilt BRET Office of Career Development interviews biomedical science PhD and postdoctoral alumni about their career path.
…
continue reading
Weekly podcast exploring China's business and financial sectors from a legal perspective, brought to you by China Law & Practice. Hosted by Vincent Chow.
…
continue reading
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team an ...
…
continue reading
1
The Editors’ Roundtable: A 2025 Retrospective Of The Life Science Industry
1:20:48
1:20:48
Play later
Play later
Lists
Like
Liked
1:20:48
In this special edition of “Better Biopharma,” host Tyler Menichiello is joined by fellow chief editors from across the Life Science Connect ecosystem to reflect on the year and share their industry outlooks for 2026. This editorial roundtable features Katie Anderson, chief editor at Pharmaceutical Online; Jeff Buguliskis, Ph.D., deputy chief edito…
…
continue reading
1
Automating Biopharma Workflows with AI and Robotics
37:48
37:48
Play later
Play later
Lists
Like
Liked
37:48
Karthik Raman, co-founder and CEO of Persist AI, sits down with the Nagaraja Srivatsan to discuss how robotics, AI, and cloud tech are supercharging drug formulation to address a bottleneck in pharma R&D. He explains how robots outperform humans in consistency and scale, igniting a flywheel of faster prototyping, richer data, and AI-orchestrated wo…
…
continue reading
1
A year in review and what 2026 holds for biopharma and healthcare
1:14:52
1:14:52
Play later
Play later
Lists
Like
Liked
1:14:52
As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research cuts, vaccine policy fights and leadership churn at the FDA, then push the conversation forward into the questions that will shape 2026. The through l…
…
continue reading
1
217: Silkworm Biomanufacturing: From Ancient Silk Production to Phase I Vaccine Trials with Masafumi Osawa - Part 1
25:29
25:29
Play later
Play later
Lists
Like
Liked
25:29
For over 4,000 years, silkworms have connected civilizations through ancient trade routes. Now, KAICO Ltd., a Japanese biotech spin-off from Kyushu University, is transforming these creatures into living bioreactors capable of producing complex recombinant proteins and vaccine antigens—without the bioreactors, expensive media, or massive water cons…
…
continue reading
1
Building a Nasal First line of Defense Against H5N1
34:48
34:48
Play later
Play later
Lists
Like
Liked
34:48
Intranasal vaccines are back in the spotlight as highly pathogenic avian influenza spreads among birds and spills over into mammals, including recent cases in dairy and poultry workers. In this episode of In Vivo, senior pharma and biotech reporter David Wild talks with Chad Costley, CEO of BlueWillow Biologics and Meagan Deming, an infectious dise…
…
continue reading
1
Life Science Connect Editors' Roundtable: Wrapping Up 2025 And Looking Ahead
1:21:12
1:21:12
Play later
Play later
Lists
Like
Liked
1:21:12
We love to hear from our listeners. Send us a message. This week's special holiday episode of the Business of Biotech brings seven chief editors from the Life Science Connect family together to talk about the life sciences industry topics, trips, and reporting that mattered most in 2025, and what each editor has planned for 2026. From the RNA, cell…
…
continue reading
1
2025 US Policy Highlights - Inflation Reduction Act (IRA) Part 2
38:55
38:55
Play later
Play later
Lists
Like
Liked
38:55
In this special 2025 U.S. Policy Highlights edition of the Vital Health Podcast, we look back at our most important discussions on the Inflation Reduction Act (IRA) and its ripple effects across drug development, Medicare, and patient access. Over the past year, the biopharma industry and the broader healthcare system have undergone a period of rap…
…
continue reading
1
From discovery to delivery: AI’s impact on nanomedicine
46:31
46:31
Play later
Play later
Lists
Like
Liked
46:31
In this episode of Data in Biotech, Ross Katz chats with Mitra Mosharraf, Chief Scientific Officer at HTD Biosystems, about how AI and machine learning are revolutionizing nanomedicine. They explore the use of AI in drug discovery, formulation, manufacturing, and clinical development, highlighting how data-driven strategies are improving safety, re…
…
continue reading
1
31: EU GMP Chapter 1 Update: The quiet rewrite that may change QRM auditability.
37:11
37:11
Play later
Play later
Lists
Like
Liked
37:11
In this episode, Lori and Val explore the proposed update to Chapter 1 of the EU GMPs - Eudralex Volume 4. The update solidifies formality in Quality Risk Management and is clear that it expects subjectivity to be minimized. Join us as we discuss what this means in reality and how moving these expectations from a guidance to an inspection standard …
…
continue reading
1
Decoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology
25:51
25:51
Play later
Play later
Lists
Like
Liked
25:51
This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology share a bold new approach to fighting diseases of aging before they take hold. Instead of testing one drug at a time, their technology allows scientists to test hundreds of potential treatments at once, making drug discovery faster and more prec…
…
continue reading
1
E198: Podcast with Cures & Capital Part 1
28:11
28:11
Play later
Play later
Lists
Like
Liked
28:11
In this episode, Dr. Andre Bates, Founder & CEO of Eularis, joins Cures and Capital hosts Martin and Simon for a deep dive into how AI is transforming the biopharma industry. With over two decades of experience applying AI across R&D, clinical development, regulatory, medical affairs, and commercial teams, Dr. Bates explains how the field has evolv…
…
continue reading
1
Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos
46:39
46:39
Play later
Play later
Lists
Like
Liked
46:39
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big pharma decision-making processes, and dosing the first patient with Kenai's allogeneic neuron…
…
continue reading
1
Jaidev Chakka on building the future of bioprinted medicine
45:24
45:24
Play later
Play later
Lists
Like
Liked
45:24
In this episode of Data in Biotech, Ross Katz chats with Jaidev Chakka, Principal Scientist at the University of Mississippi School of Pharmacy, about how 3D bioprinting and AI are reshaping pharmaceutical manufacturing. They explore the development of custom scaffolds for tissue engineering, the integration of gene delivery systems, and how data-d…
…
continue reading
1
2025 US Policy Highlights - Most Favored Nation (MFN)
51:18
51:18
Play later
Play later
Lists
Like
Liked
51:18
In this special 2025 U.S. Policy Highlights edition of the Vital Health Podcast, we look back at our most important discussions on Most Favored Nation (MFN) drug pricing and its knock-on effects for jobs, state budgets, and the generic supply chain. Over the past year, proposals to link U.S. prices to those in other countries have collided with inf…
…
continue reading
1
E197: Inside the AI Factory: How AI Systems Builds Workflows That Actually Work
30:05
30:05
Play later
Play later
Lists
Like
Liked
30:05
In this episode, we take you inside the AI factory — the place where companies are transforming real business operations using AI workflows, not just experimenting with flashy demos or proofs of concept. AI strategist Dustin Jensen breaks down what differentiates AI systems that scale from those that become expensive experiments. He explains why co…
…
continue reading
1
When Your Immune System Overreacts...Prof. Dr. Niels Riedemann, Co-Founder & CEO, InflaRx
21:52
21:52
Play later
Play later
Lists
Like
Liked
21:52
This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to …
…
continue reading
1
From screening to IND: How Veloxity accelerates critical drug decisions
25:34
25:34
Play later
Play later
Lists
Like
Liked
25:34
In this episode of Data in Biotech, Ross Katz sits down with Callie Celichowski and Isa Kupke from Veloxity Labs to discuss how their CRO leverages speed, precision, and innovation to support drug development. Learn how they use mass spectrometry, cloud-based infrastructure, and hands-on client partnerships to drive rapid, high-quality bioanalytica…
…
continue reading
1
Modernizing Clinical Trial Operations With Merck's Jennifer Sheller
55:39
55:39
Play later
Play later
Lists
Like
Liked
55:39
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Jennifer Sheller, SVP and Head of Global Clinical Trial Operations at Merck talks about simplifying trial protocols and what she likes about Merck's hybrid functional service provider model for conducting trials in over 60 countries. Jennifer s…
…
continue reading
1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
16:28
16:28
Play later
Play later
Lists
Like
Liked
16:28
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月19日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本期要闻——再生元夹在成功与专利到期之间；第三季度十大畅销药物；礼来Retatrutide重塑减重标准；辉瑞坚守疫苗投资；赛诺菲在托布替尼困境中仍保持乐观。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XA4W4OYCVRCSNHW5ZL7TUFJF2U/Playlist: on.soundcloud.com/gnr7PaOwflN…
…
continue reading
1
Scrip's Five Must-Know Things - Dec. 22, 2025
16:38
16:38
Play later
Play later
Lists
Like
Liked
16:38
Audio roundup of selected biopharma industry content from Scrip over the business week ended December 19, 2025. This episode was produced with the help of AI text-to-voice and voice emulation tools.This time – Regeneron caught between success and expiry; Q3’s top 10 drugs; Lilly’s Retatrutide Raises Weight-Loss Bar; Pfizer stands by vaccines invest…
…
continue reading
1
Revitalizing Pharma Collaborations: The Reblozyl Case Study
44:10
44:10
Play later
Play later
Lists
Like
Liked
44:10
In this episode of IDEA Collider, hosts Mike and Rick revisit a pivotal project from over a decade ago, the Reblozyl project, undertaken in collaboration with Acceleron and Celgene. Rick, the head of Growth and Innovation at IDEA, reminisces about the early days leading to the successful positioning and market shaping of luspatercept across differe…
…
continue reading
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026By John Simboli
…
continue reading
1
2025 U.S. Policy Highlights - Inflation Reduction Act (IRA) Part 1
37:38
37:38
Play later
Play later
Lists
Like
Liked
37:38
In this special 2025 U.S. Policy Highlights edition of the Vital Health Podcast, we look back at our most important discussions on the Inflation Reduction Act (IRA) and its ripple effects across drug development, Medicare, and patient access. Over the past year, the biopharma industry and the broader healthcare system have undergone a period of rap…
…
continue reading
1
“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
52:32
52:32
Play later
Play later
Lists
Like
Liked
52:32
Matthew Wood, director and chief scientific officer at Oxford-Harrington Rare Disease Center, discusses the state of rare disease R&D, the evolving landscape of genomics and genetic therapies, and the challenges around the biopharma industry’s narrow focus on only 5-10% of rare diseases.By Citeline
…
continue reading
This podcast brings you highlights from Scrip Awards 2025, including wins for AstraZeneca, Syndax, Akeso and Summit Therapeutics and the Lifetime Achievement Award for Flagship Pioneering's Noubar Afeyan.By Citeline
…
continue reading
1
Datamonitor Healthcare Podcast: A Deep Dive into Dry AMD
14:37
14:37
Play later
Play later
Lists
Like
Liked
14:37
Emma Wille and Summer Colling speak with ophthalmology expert, Joseph Jacob, to discuss the latest developments in dry age-related macular degeneration (dry AMD), including current treatments, emerging therapies, regulatory challenges, and the unmet needs shaping the future of patient care.By Citeline
…
continue reading
Many leaders are wondering about when their company will see a return on its AI investment. On this episode of At the Edge, Elad Gil—technology angel investor, AI expert, and entrepreneur—says most companies and organizations will need at least ten years to fully integrate AI into their everyday processes, even as its value is already proving itsel…
…
continue reading
1
Scott Stout, CEO & Co-Founder at MedVector Clinical Trials
36:09
36:09
Play later
Play later
Lists
Like
Liked
36:09
This episode features Scott Stout, who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and more diverse patient populations for clinical trial sites. Their approach allows trusted healthcare providers and their patie…
…
continue reading
1
Ep. 99 – Stelios Papadopoulos on Biotech’s Long View: Pricing Pressure, China & Big Pharma
37:59
37:59
Play later
Play later
Lists
Like
Liked
37:59
In historical terms, this is not a bear market, says Stelios Papadopoulos. There’s volatility, which is unnerving, and major issues to reckon with, but the level of anxiety in biotech doesn’t reflect the “extraordinary science, the likes of which we’ve never seen — and it’s getting better,” said Papadopoulos on The BioCentury Show. Papadopoulos is …
…
continue reading
1
2025 CNS Summit Series: Revolutionizing Clinical Trials with Virtual Patients, A Conversation with Anzar Abbas, CEO, Brooklyn Health
13:48
13:48
Play later
Play later
Lists
Like
Liked
13:48
What’s the path to better measurement in psychiatry? In this episode, Dr. Alexandria Wise speaks with Dr. Anzar Abbas—neuroscientist, innovator and CNS Summit 2025 Innovation Showcase winner—about how Brooklyn Health is using AI to standardize rater training and improve data quality in psychiatric trials. They discuss why subjective interviews stil…
…
continue reading
1
Breakthroughs and Trends That Defined Lab Medicine in 2025
12:55
12:55
Play later
Play later
Lists
Like
Liked
12:55
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025. Staying healthy during the holidays (00:18): Disco…
…
continue reading
1
216: From Data Silos to Autonomous Biomanufacturing: Digital Twins and AI-Driven Scale-Up with Ilya Burkov - Part 2
18:33
18:33
Play later
Play later
Lists
Like
Liked
18:33
Biomanufacturing has always dealt with the challenge of turning vast, complex datasets and intricate production steps into life-changing therapies. But when batch records multiply and process deviations loom, how do biotech teams make sense of it all? In this episode, we move beyond theory to the nuts and bolts of how AI - when thoughtfully deploye…
…
continue reading
1
Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo
17:47
17:47
Play later
Play later
Lists
Like
Liked
17:47
This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a crucial mistake in the trial data. Now with new insights an…
…
continue reading
1
Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech
34:25
34:25
Play later
Play later
Lists
Like
Liked
34:25
Synopsis: This episode is proudly sponsored by Quartzy.Roivant Sciences CEO Matt Gline returns to Biotech 2050 for a deeply reflective conversation with host Rahul Chaturvedi on what it really takes to build a biotech company that lasts. From Roivant’s transformational $7B Pfizer-to-Roche deal to delivering registrational Phase 3 data in dermatomyo…
…
continue reading
1
Combining AI With Operations Research To Advance Biomanufacturing With Tinglong Dai, Ph.D., and Tugce Martagan, Ph.D.
35:28
35:28
Play later
Play later
Lists
Like
Liked
35:28
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Tinglong Dai, Ph.D., Bernard T. Ferrari Professor of Business at Johns Hopkins University, and Tugce Martagan, Ph.D., associate professor at Northeastern University, to talk about the potential advancements that can be made in biomanufacturing by combining AI with operations…
…
continue reading
1
E196: Simplify to Scale: Using AI and Design Thinking to Cut Complexity and Grow Smarter
27:52
27:52
Play later
Play later
Lists
Like
Liked
27:52
In today’s episode, we explore the Simplify to Scale approach — how companies can use AI, intelligent automation, and design thinking to remove operational friction, improve workflows, and unlock sustainable growth. Our guest, Anthony Franco, is a serial entrepreneur, AI strategist, and co-author of AI First Principles and The Wiser Method. He has …
…
continue reading
Humanoid robots don’t live in sci-fi movies only anymore. Agility Robotics’ creations are helping workers in real places—warehouses, shop floors, distribution centers—do their jobs more efficiently, safely, and precisely. On this episode of the At the Edge podcast, Agility’s CEO, Peggy Johnson, speaks to McKinsey Senior Parter Lareina Yee about the…
…
continue reading
1
Scrip M&A Podcast: PwC's Dealmaking Preview for 2026
32:32
32:32
Play later
Play later
Lists
Like
Liked
32:32
Scrip senior writer Joseph Haas and PwC analyst Roel Van den Akker look back on biopharma sector dealmaking in 2025, why deal values rose from 2024's lows, and look ahead to what the trends mean heading into 2026 in this latest edition of the Scrip M&A Podcast.By Citeline
…
continue reading
1
Optimizing Stakeholder Engagement for Timely Completion of Clinical Trials with Kimberly Guedes
31:36
31:36
Play later
Play later
Lists
Like
Liked
31:36
Discover practical strategies for building cross-functional alignment and trust to ensure faster, more efficient completion of clinical trials. Featuring: Kimberly Guedes, VP Clinical Operations, Intensity Therapeutics (LinkedIn), keynote speaker at COG Bay Area Recorded live at COG Bay Area, this episode delivers a candid, operationally focused ke…
…
continue reading
1
215: From Data Silos to Autonomous Biomanufacturing: Digital Twins and AI-Driven Scale-Up with Ilya Burkov - Part 1
21:34
21:34
Play later
Play later
Lists
Like
Liked
21:34
Across biotech labs, researchers swim in oceans of process data: sensor streams, run records, engineering logs, and still, crucial decisions get stuck in spreadsheets or scribbled into fading notebooks. The challenge isn’t having enough information, it's knowing which actions actually move the needle in cell culture productivity, process stability,…
…
continue reading
1
Revolutionizing bioanalysis with high-resolution mass spec
32:31
32:31
Play later
Play later
Lists
Like
Liked
32:31
In this episode of Data in Biotech, host Ross Katz sits down with Eshani Galermo, Staff Scientist at SCIEX, to explore the next generation of mass spectrometry in pharma and biopharma. Eshani explains how innovations like the ZenoTOF 8600 are redefining sensitivity, selectivity, and workflow efficiency in bioanalytical chemistry. Discover how high-…
…
continue reading
1
Formulation as Strategy: Why CDMOs Matter More Than Ever
45:54
45:54
Play later
Play later
Lists
Like
Liked
45:54
Episode Title: Formulation as Strategy: Why CDMOs Matter More Than Ever Guest: Elizabeth Hickman, President & CEO, Austin Pharmaceutics Episode Overview In this episode of RealPharma, hosts Nari Oh and Ian Wendt sit down with Elizabeth Hickman, President and CEO of Austin Pharmaceutics, to unpack one of the most critical—and often misunderstood—ele…
…
continue reading
1
Transforming Chronic Kidney Disease With ProKidney's Bruce Culleton, M.D.
55:36
55:36
Play later
Play later
Lists
Like
Liked
55:36
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Bruce Culleton, M.D., CEO at ProKidney, talks about moving from academic research to industry and the role a key mentor played in his career path. Bruce discusses his experiences as a first-time CEO at ProKidney, a late-stage autologous cell th…
…
continue reading
1
In Silico Modeling: A Drug Developer's Superpower
30:09
30:09
Play later
Play later
Lists
Like
Liked
30:09
Developing complex biologics and advanced therapies is historically time-consuming and material-intensive—but computational modeling is reshaping the formulation landscape. In this episode of Life Science Solutions, host Chris Adkins is joined by Andrea Arsiccio, PhD, Senior Scientist and Team Lead In Silico at Coriolis Pharma, to discuss how in si…
…
continue reading
1
Scrip 五件必知要闻: 药闻周析 - 全球制药风云聚焦 (Chinese-language podcast)
17:59
17:59
Play later
Play later
Lists
Like
Liked
17:59
本期播客内容来自《Scrip》杂志，精选内容涵盖截至2025年12月12日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。本期聚焦美国血液学会（ASH）会议五大关键成果：Jaypirca有望成为一线疗法；Kite公司Anito-cel在多发性骨髓瘤领域的进展；新一代CAR-T疗法；Kelownia公司CAR-T疗法的早期体内数据；以及诺华公司ianalumab在ITP治疗中的潜力。Story links: https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-RFOOY2665REEZ…
…
continue reading
1
Scrip's Five Must-Know Things - Dec. 15, 2025
17:51
17:51
Play later
Play later
Lists
Like
Liked
17:51
Audio roundup of selected biopharma industry content from Scrip over the business week ended December 12, 2025. This week, a focus on five key results from the American Society of Hematology (ASH) meeting – Jaypirca headed for the front line; Kite’s Anito-cel in multiple myeloma; next-generation CAR-T approaches; Kelownia’s early in vivo CAR-T data…
…
continue reading
